期刊文献+

益生菌修复幽门螺杆菌相关黏膜屏障破坏的机制 被引量:9

Mechanisms underlying role of probiotics in recovering Helicobacter pylori-associated intestinal mucosal barrier damage
下载PDF
导出
摘要 幽门螺杆菌(Helicobacter pylori,H.pylori)自发现至今被认为能够导致多种疾病的发生,包括消化性溃疡、慢性胃炎、胃癌以及胃淋巴细胞相关性肿瘤.近年来传统三联疗法(质子泵抑制剂+两种抗生素)对于H.pylori根除率明显下降,这与细菌耐药性的增强有关.在传统三联疗法基础上添加益生菌能够有效的提高H.pylori根除率,同时降低不良反应的发生.其机制可能为益生菌能够修复H.pylori引起的化学屏障、生物屏障、机械屏障以及免疫屏障的破坏,恢复消化系正常防御功能,从而辅助H.pylori根除.此文将就益生菌修复H.pylori相关消化系屏障功能破坏的具体机制进行综述. Helicobacter pylori (H. pylori) is closely associated with many gastrointestinal diseases, including peptic ulcers, chronic gastritis, gastric cancer and gastric mucosa-associated lymphoid tumors. In recent year, traditional triple therapy for H. pylori eradication has become less effective than the past, which is related to the resistance of bacteria. The addition of probiotics into the regimen has been proved to be able to significantly enhance the eradication rate and reduce side effects. Probiotics increase the eradication of H. pylori by recovering the damage of the chemical barrier, biological bar- rier, mechanical barrier and immune barrier.
出处 《世界华人消化杂志》 CAS 北大核心 2013年第28期2981-2986,共6页 World Chinese Journal of Digestology
关键词 幽门螺杆菌 益生菌 黏膜屏障 Helicobacterpylori Probiotic Intestinalmucosal barrier
  • 相关文献

参考文献48

  • 1Navarro-Rodriguez T, Silva FM, Barbuti RC, Mat-tar R, Moraes-Filho JP, de Oliveira MN, BogsanCS, Chinzon D, Eisig JN. Association of a probioticto a Helicobacter pylori eradication regimen doesnot increase efficacy or decreases the adverse ef-fects of the treatment: a prospective, randomized,double-blind, placebo-controlled study. BMCGastroenterol 2013; 13: 56 [PMID: 23530767 DOI:10.1186/1471-230X-13-56].
  • 2Ahmad K, Fatemeh F, Mehri N, Maryam S. Probiot-ics for the treatment of pediatric helicobacter pyloriinfection: a randomized double blind clinical trial.Iran J Pediatr 2013; 23: 79-84 [PMID: 23446685].
  • 3Go MF. Review article: natural history and epidemi-ology of Helicobacter pylori infection. Aliment Phar-macol Ther 2002; 16 Suppl 1: 3-15 [PMID: 11849122].
  • 4Linz B, Balloux F, Moodley Y, Manica A, Liu H,Roumagnac P, Falush D, Stamer C, Prugnolle V, vander Merwe SW, Yamaoka Y, Graham DY, Perez-Trallero E, Wadstrom T, Suerbaum S, AchtmanM. An African origin for the intimate associationbetween humans and Helicobacter pylori. Nature2007; 445: 915-918 [PMID: 17287725].
  • 5Du YQ, Su T, Fan JG, Lu YX, Zheng P, Li XH, GuoCY, Xu P, Gong YF, Li ZS. Adjuvant probioticsimprove the eradication effect of triple therapy forHelicobacter pylori infection. World J Gastroenterol2012; 18: 6302-6307 [PMID: 23180952 DOI: 10.3748/wjg.vl8.i43.6302].
  • 6Lesbros-Pantoflickova D, Corthesy-Theulaz I, BlumAL. Helicobacter pylori and probiotics. ] Nutr 2007;137: 812S-818S [PMID: 17311980].
  • 7Wang ZH, Gao QY, Fang JY. Meta-analysis of theefficacy and safety of Lactobacillus-containing andBifidobacterium-containing probiotic compoundpreparation in Helicobacter pylori eradicationtherapy. / Clin Gastroenterol 2013; 47: 25-32 [PMID:23090045 DOI: 10.1097/MCG.0b013e318266f6cf].
  • 8Wilhelm SM, Johnson JL, Kale-Pradhan PB. Treatingbugs with bugs: the role of probiotics as adjunctivetherapy for Helicobacter pylori. Ann Pharmacother2011; 45: 960-966 [PMID: 21693698 DOI: 10.1345/aph.lQ104].
  • 9Ya§ar B, Abut E, Kayadibi H, Toros B, Sezikli M,Akkan Z, Keskin O, Ovung Kurda§ O. Efficacyof probiotics in Helicobacter pylori eradicationtherapy. Turk J Gastroenterol 2010; 21: 212-217 [PMID:20931422].
  • 10Hurduc V, Plesca D, Dragomir D, Sajin M, Vanden-plas Y. A randomized, open trial evaluating the ef-fect of Saccharomyces boulardii on the eradicationrate of Helicobacter pylori infection in children.Acta Paediatr 2009; 98: 127-131 [PMID: 18681892DOI: 10.1111/j.l651-2227.2008.00977.x].

二级参考文献2

共引文献11

同被引文献104

引证文献9

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部